Investindustrial, a leading European group in the field of private equity, has signed an agreement through one of its investment vehicles for the entry of QuattroR into the capital of Medical Technology and Devices Group. MTD is an international group active in the design and manufacture of medical devices for home and professional care.
Investindustrial and the Italian private equity fund QuattroR will support MTD, globally recognized in the diabetes management and self-care devices markets, in expanding its product offerings and strengthening its presence in Europe and strategic markets in the United States.
MTD was born in 2018 through the combination of two historically well-established and leading players in the healthcare industry: Pikdare and HTL-Strefa, with a combined experience of more than 80 years.
Bär & Karrer acted as legal advisor to Investindustrial in this transaction. The team was led by partner Paolo Bottini (pictured left), associates Andrea Ziswiler (both corporate and m&a) and Michel Morelato (tax) and included Rocco Rigozzi, Saliba Betar and Nick Wälti (all corporate and m&a), Massimo Vanotti (notarial services), Bryan Bruschi (employment), Susanne Schreiber and Leotrim Berisha (both tax).
Loyens & Loeff advised QuattroR in its co-investment with Investindustrial in MTD Medical Technology and Devices Group. The team, composed by partner Marco Toni (pictured right), associate Gilles Pitschen (both from Zurich) as well as partner Siobhán McCarthy (Luxembourg), acted as Swiss and Luxembourg legal counsel and assisted on all corporate aspects of the transaction for QuattroR. alongside KPMG, Bain & Co., GPBL, Cleary Gottlieb and ERM.